LSP, the leading life sciences investor in Europe, has held its final close of LSP 6 at the $600 million hard cap. This is the largest fund ever raised in Europe focused on life sciences ventures. LSP currently has $1.1 billion of capital to invest across LSP 6, the LSP Health Economics Fund and LSP’s public fund and mandates.

Inotec AMD, a Cambridge based, fast-growing medtech business that has developed a novel device capable of healing complex chronic wounds, has secured investment of £7m. The funding round was led by Praetura Capital, with involvement from Boundary Capital.

The business has developed a world leading medtech product, called NATROX® Oxygen, for use in Wound Therapy. It generates pure humidified oxygen to treat a range of chronic wounds, from diabetic and venous ulcers to non-healing surgical wounds.

The o2h Therapeutics and AI Fund, hjas invested in Neurofenix, an innovative digital health company empowering stroke survivors and their families to get their life back.

The o2h Therapeutics and AI Fund, an early stage S/EIS fund investing in biotechnology therapeutics and related AI opportunities, has made an investment in Turbine, a simulation-based drug discovery company.

Based on a decade of research, Turbine’s biologists, bioinformaticians, data scientists, and AI engineers built the Simulated Cell. This platform is comprised of a dynamic computational model of the human cell and the underlying simulation technology to find the smartest route to novel targets, biomarkers, and combination therapies.

Award winnning Active Needle is seeking £150,000 for market entry.

Montis Biosciences announced its launch with €8.4 million in seed financing from an international investor syndicate.

Inotec AMD, a fast-growing medtech business that has developed an innovative device to heal and treat complex chronic wounds, has secured £7m in a funding round led by Praetura Ventures.  The business has developed Natrox, a cutting-edge product that uses pure humidified oxygen to treat a range of chronic wounds, from diabetic and venous ulcers to non-healing surgical wounds. Following several successful clinical trials, Inotec AMD is looking to expand its foothold in the US, Asia, the Middle East and Europe. The business currently provides products to the NHS and health providers in key markets including the US, Italy, Southeast Asia and the Middle East.

Unmind, the workplace mental health platform, today announced it has raised 10 million dollars in a Series A funding round.

Led by Berlin-based Project A, with the continued support of Felix Capital, the funding – which is one of the largest series A rounds for a European mental health tech business – will support company growth, and its commitment to measurably improve the mental health of employees in workplaces around the world.

The winners of the ‘Welsh Innovation of the Year Award’ at the Welsh SME Business Awards 2019, Forth, are set to turnover £1million this year following a £250,000 equity investment from the Development Bank of Wales.

Foresight has made a £500,000 growth capital investment into Novel Technologies Holding Limited, developers of antimicrobial technology SILVERbac.  This is the third investment made by the £20 million Foresight Scottish Growth Fund which is financed by the Scottish Growth Scheme through a combination of Scottish Government funds and the European Regional Development Fund (ERDF), and is part of a wider £2.1 million funding round for NTH.

Healthcare investment vehicle Impel Healthcare Catalyst has made an additional seven figure investment into its portfolio business Trio Healthcare.

The funding will be used to fast-track the development of Trio’s production facility at its state-of-the-art manufacturing plant in Skipton, Yorkshire, ahead of the anticipated launch of a world’s first product for the ostomy market later this year.

A rapidly growing healthtech start-up on a mission to solve the NHS staffing crisis and bring flexible working to thousands of clinicians has secured £3m in a funding round led by Praetura Ventures. The round included additional backing from BMJ, the publisher behind The BMJ, and some existing angel investors. 

Patchwork, which has offices in London, Manchester and Liverpool, was founded by NHS doctors Anas Nader and Jing Ouyang in 2016 to help hospitals fill vacant shifts more cost-effectively and to stem the tide of clinicians leaving the health service due to poor work-life balance.